Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

  1. Lobbyist name (consultant or in-house lobbyist): DOBSON, JACQUELINE OR;
  2. Responsible officer name: DOBSON, JACQUELINE
Share this search Create an alert

Refine registrations results by

Status Type Subject matter Government institutions

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (20)
Results: 1-20 | Export
  1. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Bettina Hamelin, President
    Registration: 110 of 110 (2024-04-08 to present)
    Posted: 2024-04-25
    Subject matter details: 24
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  2. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Bettina Hamelin, President
    Registration: 109 of 110 (2024-04-08 to 2024-04-08)
    Posted: 2024-04-25
    Subject matter details: 24
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  3. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: David Renwick, Interim President
    Registration: 108 of 110 (2023-12-11 to 2024-04-08)
    Posted: 2023-12-11
    Subject matter details: 29
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  4. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: David Renwick, Interim President
    Registration: 107 of 110 (2023-11-17 to 2023-12-11)
    Posted: 2023-11-17
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  5. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 106 of 110 (2023-10-23 to 2023-11-17)
    Posted: 2023-10-31
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
  6. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 105 of 110 (2023-09-11 to 2023-10-23)
    Posted: 2023-09-14
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  7. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 104 of 110 (2023-06-16 to 2023-09-11)
    Posted: 2023-06-19
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  8. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 103 of 110 (2023-06-09 to 2023-06-16)
    Posted: 2023-06-12
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
  9. Janssen Inc.
    Type: In-house Corporation
    Responsible officer: Jorge Bartolome, President
    Registration: 30 of 38 (2020-12-14 to 2022-01-31)
    Posted: 2020-12-15
    Subject matter details: 13
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  10. Janssen Inc.
    Type: In-house Corporation
    Responsible officer: Jorge Bartolome, President
    Registration: 29 of 38 (2020-11-14 to 2020-12-14)
    Posted: 2020-11-16
    Subject matter details: 12
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  11. Janssen Inc.
    Type: In-house Corporation
    Responsible officer: Jorge Bartolome, President
    Registration: 28 of 38 (2020-04-01 to 2020-11-14)
    Posted: 2020-05-13
    Subject matter details: 12
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  12. Janssen Inc.
    Type: In-house Corporation
    Responsible officer: Jorge Bartolome, President
    Registration: 27 of 38 (2020-01-20 to 2020-04-01)
    Posted: 2020-01-21
    Subject matter details: 11
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 12
  13. Janssen Inc.
    Type: In-house Corporation
    Responsible officer: Jorge Bartolome, President
    Registration: 25 of 38 (2019-09-03 to 2019-09-03)
    Posted: 2019-09-20
    Subject matter details: 11
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 12
  14. Janssen Inc.
    Type: In-house Corporation
    Responsible officer: Jorge Bartolome, President
    Registration: 26 of 38 (2019-09-03 to 2020-01-20)
    Posted: 2019-10-03
    Subject matter details: 11
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 12
  15. Janssen Inc.
    Type: In-house Corporation
    Responsible officer: Chris Halyk, General Manager
    Registration: 24 of 38 (2019-05-09 to 2019-09-03)
    Posted: 2019-06-06
    Subject matter details: 11
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 12
  16. Janssen Inc.
    Type: In-house Corporation
    Responsible officer: Chris Halyk, General Manager
    Registration: 23 of 38 (2019-05-01 to 2019-05-09)
    Posted: 2019-05-02
    Subject matter details: 12
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 12
  17. Janssen Inc.
    Type: In-house Corporation
    Responsible officer: Chris Halyk, General Manager
    Registration: 22 of 38 (2018-10-31 to 2019-05-01)
    Posted: 2018-11-15
    Subject matter details: 12
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  18. Janssen Inc.
    Type: In-house Corporation
    Responsible officer: Chris Halyk, General Manager
    Registration: 21 of 38 (2018-09-26 to 2018-10-31)
    Posted: 2018-09-26
    Subject matter details: 12
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  19. Janssen Inc.
    Type: In-house Corporation
    Responsible officer: Chris Halyk, General Manager
    Registration: 20 of 38 (2018-04-18 to 2018-09-26)
    Posted: 2018-04-20
    Subject matter details: 12
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  20. Janssen Inc.
    Type: In-house Corporation
    Responsible officer: Chris Halyk, General Manager
    Registration: 19 of 38 (2017-09-16 to 2018-04-17)
    Posted: 2017-10-02
    Subject matter details: 11
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9

Date Modified: